ECM
ARNA

ETrade Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

ETrade Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$638K Buy
8,536
+4,324
+103% +$288K 0.01% 495
2020
Q2 		$265K Sell
4,212
-707
-14% -$38.9K 0.01% 697
2020
Q1 		$206K Buy
+4,919
New +$226K 0.01% 682

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

ETrade Capital Management's ARNA Position: Q3 2020 in Review

ETrade Capital Management increased its Arena Pharmaceuticals Inc (ARNA) stake by 103% in Q3 2020, buying an estimated $288K and bringing the position to 8,536 shares worth $638K. The position accounts for 0.01% of the portfolio, ranked #495.

ETrade Capital Management first reported a position in ARNA in Q1 2020 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • ETrade Capital Management held 8,536 shares of Arena Pharmaceuticals Inc worth $638K as of Q3 2020.
  • ETrade Capital Management bought 4,324 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $288K.
  • Arena Pharmaceuticals Inc made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #495 holding.
  • ETrade Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.